COMPLEMENT
ACTIVATION
AND
PULMONARY
INFLAMMATION
IN
CF
PATIENTS
THIS
STUDY
EXAMINED
WHETHER
BIOLOGIC
ACTIVATION
OF
C3
WITH
SUBSEQUENT
PULMONARY
INFLAMMATION
TAKES
PLACE
IN
THE
LUNGS
OF
PATIENTS
WITH
CYSTIC
FIBROSIS
PLASMA
COMPLEMENT
C3
LEVELS
WERE
ALL
NORMAL
ELEVEN
OF
THE
PATIENTS
WITH
THE
C3
SPLIT
PRODUCT
C3C
WERE
FROM
THE
GROUP
OF
14
PATIENTS
SUFFERING
FROM
CHRONIC
INFECTION
WITH
MUCOID
STRAINS
OF
PSEUDOMONAS
AERUGINOSA
AND
2
WERE
FROM
THE
GROUP
OF
14
CF
PATIENTS
WITHOUT
P
AERUGINOSA
INFECTION
THIS
DIFFERENCE
WAS
SIGNIFICANT
P

0002
A
COMPARISON
OF
ALBUMIN
RATIOS
BETWEEN
THE
13
PATIENTS
WITH
THE
C3
SPLIT
PRODUCT
C3C
AND
THE
REMAINING
OTHER
15
PATIENTS
SHOWED
A
SIGNIFICANT
HIGHER
RATIO
IN
THE
FORMER
GROUP
P

001
ON
AN
AVERAGE
41
VERSUS
14
PER
CENT
THE
SIGNIFICANTLY
HIGHER
ALBUMIN
RATIO
DEMONSTRATED
IN
THE
PATIENTS
WITH
C3C
IN
THEIR
SPUTUM
SOL
PHASE
SUPPORTS
THE
CONCEPT
OF
COMPLEMENTINDUCED
INFLAMMATION
WITH
SUBSEQUENT
TRANSUDATION
OF
PLASMA
PROTEINS
IN
THESE
PATIENTS
THIS
STUDY
THUS
SHOWS
THAT
COMPLEMENTMEDIATED
INFLAMMATORY
REACTIONS
MAY
PLAY
AN
IMPORTANT
ROLE
IN
THE
PATHOGENESIS
OF
PULMONARY
TISSUE
DAMAGE
IN
PATIENTS
WITH
CF
EVEN
WHEN
THE
PLASMA
C3
LEVELS
ARE
NORMAL
AND
IT
SUPPORTS
THE
CONCEPT
OF
CHRONIC
P
AERUGINOSA
LUNG
INFECTION
AS
AN
IMMUNE
COMPLEX
DISEASE
IN
CF
PATIENTS
